Search results for "Lymphatic"

showing 10 items of 1179 documents

Brain and Cancer: The Protective Role of Erythropoietin

2005

Erythropoietin (Epo) is a pleiotropic agent, that is to say, it can act on several cell types in different ways. An independent system Epo/Epo receptor (EpoR) was detected in brain, leading to the hypothesis that this hormone could be involved in cerebral functions. Epo/EpoR expression changes during ontogenesis, thus indicating the importance of this system in neurodevelopment. Moreover, the hypoxia-induced production of Epo in the adult brain suggests that it could exert a neurotrophic and neuroprotective effect in case of brain injury. Epo could also influence neuro- transmission, inducing neurotransmitters (NT) release. Epo therapy in anemic cancer patients is still a controversial issu…

Cell typeCentral nervous systemPharmacologyModels BiologicalNeuroprotectionNeoplasmshemic and lymphatic diseasesDrug DiscoveryReceptors ErythropoietinmedicineAnimalsHumanscancerReceptorPleiotropyPharmacologyNeurotransmitter AgentsNeovascularization Pathologicbiologyhypoxiabusiness.industryMedicine (all)Organic ChemistryBrainangiogenesiGeneral MedicineNeuroprotectionneuroprotective effectErythropoietin receptorErythropoietin (Epo); brain; central nervous system (CNS) diseases; neuroprotective effectmedicine.anatomical_structureErythropoietin (Epo)Erythropoietinbiology.proteinMolecular MedicineerythropoietinSignal transductionbusinessNeurosciencecentral nervous system (CNS) diseasesmedicine.drugNeurotrophinChemInform
researchProduct

Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma

2015

Interleukin (IL)-17A belongs to IL-17 superfamily and binds the heterodimeric IL-17 receptor (R)(IL-17RA/IL-17RC). IL-17A promotes germinal center (GC) formation in mouse models of autoimmune or infectious diseases, but the role of IL-17A/IL-17AR complex in human neoplastic GC is unknown. In this study, we investigated expression and function of IL-17A/IL-17AR in the microenvironments of 44 B cell non-Hodgkin lymphomas (B-NHL) of GC origin (15 follicular lymphomas, 17 diffuse large B cells lymphomas and 12 Burkitt lymphomas) and 12 human tonsil GC. Furthermore, we investigated the role of IL-17A in two in vivo models of GC B cell lymphoma, generated by s.c. injection of SU-DHL-4 and OCI-Ly8…

Cell typeImmunologySettore MED/08 - Anatomia PatologicaangiogenesisB non-Hodgkin lymphomahemic and lymphatic diseasesmedicineIL-17AImmunology and Allergytumor immunologyCXCL13B-cell lymphomaangiogenesis; B non-Hodgkin lymphoma; GC B cells; IL-17A; IL-17A receptor; tumor immunology; Immunology and Allergy; Oncology; ImmunologyB cellOriginal ResearchSevere combined immunodeficiencybusiness.industryIL-17A receptorGerminal centerInterleukinangiogenesimedicine.diseaseMolecular biologyGC B cellmedicine.anatomical_structureOncologyCell cultureImmunologyGC B cellsbusiness
researchProduct

Expression and Function of Class II I-Ak Antigens on an Antigen-Specific T-Suppressor Cell Clone

1986

The question of whether similar or different modes of Ia-antigen expression exist in different cell classes and mediate different cell type functions is of primary interest to current class II antigen research. Among cells of the lymphoid system in the mouse, class II antigens are primarily expressed on B lymphocytes (Sachs and Cone 1973) and cells of the macrophage lineage (Cowing et al. 1978), whereas the majority of T lymphocytes do not seem to express endogenously synthesized class II antigens.

Cell typeLineage (genetic)Lymphatic systemmedicine.anatomical_structureAntigenCellmedicineMacrophageBiologyClone (B-cell biology)Molecular biologyPan-T antigens
researchProduct

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

2002

Epitope density and organization have been shown to be important factors for B cell activation in many animal model systems. However, it has been difficult to separate the role of antigen organization from the role of local antigen concentrations because highly organized antigens are usually particulate whereas non-organized antigens are more soluble. Hence, highly organized and non-organized antigens may interact with different cell types and in different locations within lymphoid organs. In order to assess the role of antigen organization in regulating B cell responses, we immunized mice with highly repetitive virus-like particles, which exhibit different epitope densities covalently atta…

Cell typeMolecular Sequence DataImmunologyBiologyEpitopeTetraspanin 28EpitopesMiceVirus-like particleAntigenAntigens CDmedicineAnimalsImmunology and AllergyAmino Acid SequenceB cellB-LymphocytesVirionMembrane ProteinsT-Lymphocytes Helper-InducerMolecular biologyMice Inbred C57BLTiterLymphatic systemAntibody responsemedicine.anatomical_structureImmunoglobulin MImmunoglobulin GReceptors Complement 3bFemaleReceptors Complement 3dEuropean Journal of Immunology
researchProduct

Abstract PO-35: Prognostic significance of MYC, BCL2, and BCL6 colocalization at single-cell resolution in DLBCL

2020

Abstract MYC, BCL2, and BCL6 are commonly used markers for immunohistochemistry of Diffuse large B-cell lymphomas (DLBCL). Coexpression of MYC and BCL2 in particular constitutes a subgroup of “double expressor lymphomas” (DEL) with a distinct poor clinical outcome. However, it is not known if MYC and BCL2/BCL6 coexpression occurs in the same cell or in different cells within the tumor, as traditional immunohistochemistry (IHC) is limited by the number of markers that can be simultaneously assessed within formalin-fixed, paraffin-embedded (FFPE) samples. We set out to discover the clinical significance of MYC, BCL2, and BCL6 colocalization at single-cell resolution using multiplexed quantita…

CellGerminal centerColocalizationGeneral MedicineBiologyBCL6Continuous variablemedicine.anatomical_structureimmune system diseaseshemic and lymphatic diseasesTonsilCancer researchmedicineImmunohistochemistryClinical significanceBlood Cancer Discovery
researchProduct

Clastogenic and aneuploidizing effects of antiblastic busulphan revealed by kinetochore immunofluorescence in CHO cells.

1991

We utilized, in CHO cells, the cytoplasm preservation technique to evaluate the micronucleus frequency at different busulphan concentrations, and the indirect immunofluorescence technique, using sera obtained from patients with scleroderma (CREST variant), to analyze if busulphan-induced micronuclei have kinetochores. Results show that this alkylating agent is capable of causing a significant increase of micronuclei in vitro, a great part (40%) of them having CREST-positive kinetochores. These findings confirm the clastogenic effect of busulphan and reveal a considerable capability of this agent to induce aneuploidy. These results are examined taking into account the high incidence of secon…

CentromereAneuploidyFluorescent Antibody TechniqueBiologyImmunofluorescenceCell LineAcetoneClastogenhemic and lymphatic diseasesmedicineHumansBusulfanMicronuclei Chromosome-DefectiveChromosome AberrationsMicronucleus TestsScleroderma Systemicmedicine.diagnostic_testDose-Response Relationship DrugGeneral Medicinemedicine.diseaseAneuploidyMolecular biologyIn vitroCell cultureMicronucleus testMicronucleusBusulfanmedicine.drugMutation research
researchProduct

Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients

2016

none 12 Nowadays cervical cancer is frequently diagnosed at early stage. For these patients lymph node metastasis (LNM) is considered the most important prognostic factor. During the last decade many efforts have been made to reduce rate of complications associated with lymphadenectomy (LND). A great interest has arisen in sentinel lymph node (SLN) biopsy as a technique able to decrease number of LND performed and, at the same time, to assess lymph nodal status. High diagnostic performances have been reached thanks to SLN surgical algorithm. However, despite the efforts, about 25% of these patients undergo at least unilateral LND to meet NCCN recommendations. Data of women with Internationa…

Cervical cancer; early stage; lymphadenectomy; sentinel lymph node; Oncology; Radiology Nuclear Medicine and Imaging; Cancer ResearchCancer Researchmedicine.medical_treatmentUterine Cervical NeoplasmsCervical cancer; early stage; lymphadenectomy; sentinel lymph node0302 clinical medicinesentinel lymph nodeNuclear Medicine and ImagingMedicineStage (cooking)Original ResearchCervical cancer030219 obstetrics & reproductive medicinemedicine.diagnostic_testSentinel nodeMiddle Agedearly stagePrognosisOncology030220 oncology & carcinogenesisLymphatic MetastasisFemaleRadiologyAlgorithmAlgorithmsAdultmedicine.medical_specialtySentinel lymph nodeUnnecessary ProceduresHysterectomy03 medical and health sciencesBiopsyHumansRadiology Nuclear Medicine and imagingRadical HysterectomyAgedNeoplasm StagingRetrospective StudiesHysterectomybusiness.industrySentinel Lymph Node BiopsyClinical Cancer Researchmedicine.diseaseSurgerySettore MED/40 - GINECOLOGIA E OSTETRICIAlymphadenectomyCervical cancerLymph Node ExcisionLymphadenectomyNeoplasm Gradingbusiness
researchProduct

Monocytes/Macrophages Are the Major Targets of the CCL3 Chemokine Produced by CD38(+)CD49d(+) Chronic Lymphocytic Leukemia Cells

2009

Abstract Abstract 2350 Poster Board II-327 Introduction: CD38 and CD49d are associated negative prognosticators in chronic lymphocytic leukemia (CLL). Recent gene expression profiling studies comparing CLL cases expressing low versus high levels of CD38 and CD49d, identified CCL3 as a gene upregulated by CD38+CD49d+ CLL. The release of CCL3 by cultured CLL cells was also demonstrated upon CD38 triggering, and CCL3 protein was found in CLL cells from bone marrow biopsies (BMB) of CD38+ cases (Zucchetto et al., Cancer Res, 2009; 69:4001-9). Given the role of CCL3 as potent chemoattractant for different cell types, we aimed at identifying the major targets of CCL3, as produced by CD38+CD49d+ C…

ChemokineCD68medicine.medical_treatmentChronic lymphocytic leukemiaCD3MonocyteImmunologyhemic and immune systemsCell BiologyHematologyBiologyCD38medicine.diseaseBiochemistryCytokinemedicine.anatomical_structureimmune system diseaseshemic and lymphatic diseasesCancer researchmedicinebiology.proteinTumor necrosis factor alpha
researchProduct

SAT0023 Artery Tertiary Lymphoid Organs Occur in Giant Cell Arteritis

2016

Background Arteries are immuno-privileged sites. In advanced atherosclerotic lesions, however, adventitial lymphoid infiltrates, sometimes aggregated in lymphoid follicles (the so called artery tertiary lymphoid organs, ATLO), occur together with marked neoangiogenesis and lymphangiogenesis, and with the extensive induction of high endothelial venules. Objectives To investigate if tertiary lymphoid organs (TLO) are present in GCA and their formation is associated with the ectopic expression of constitutive lymphoid tissue-homing chemokines. Methods RT-PCR, immunohistochemical and immunofluorescence analysis were used to determine the presence of ectopic TLO in GCA and the expression of chem…

ChemokinePathologymedicine.medical_specialtyFollicular dendritic cellsImmunologyHigh endothelial venulesBiologyGeneral Biochemistry Genetics and Molecular BiologyLymphangiogenesisLymphatic systemRheumatologybiology.proteinmedicineImmunology and AllergyEctopic expressionCXCL13B-cell activating factorAnnals of the Rheumatic Diseases
researchProduct

Compartmentalized Production of CCL17 In Vivo

2003

Dendritic cells (DCs)**Abbreviations used in this paper: BM, bone marrow; CHS, contact hypersensitivity; cLN, cutaneous lymph node; CRP, C-reactive protein; DC, dendritic cell; DNFB, dinitrofluorobenzene; EGFP, enhanced green fluorescent protein; LC, Langerhans cell; LP, lamina propria; MACS, magnetic-activated cell sorting; mLN, mesenteric lymph node; ODN, oligodeoxynucleotide; PFA, paraformaldehyde; PP, Peyer's patch; TLR, Toll-like receptor; TRITC, tetramethylrhodamine-5-(and-6-)-isothiocyanate. fulfill an important regulatory function at the interface of the innate and adaptive immune system. The thymus and activation-regulated chemokine (TARC/CCL17) is produced by DCs and facilitates t…

Chemokineintegumentary systemImmunologySpleenStimulationBiologyAcquired immune systemCell biologymedicine.anatomical_structureLymphatic systemAntigenImmunologymedicinebiology.proteinImmunology and AllergyCCL17CD8Journal of Experimental Medicine
researchProduct